Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
[Current Status of Genetic Diagnosis of Charcot-Marie-Tooth Disease: Variety of the Disease-causing Genes].
Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
Optic neuritis: A blurry issue.
Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident optic neuritis.
Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis.
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.
Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
Acute bilateral visual loss in a young adult.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Autoimmune disease: A role for new anti-viral therapies?
Cytomegalovirus associated transverse myelitis in an immunocompetent host with DNA detection in cerebrospinal fluid; a case report.
Acute effects of walking, cycling, and yoga exercise on cognition in persons with relapsing-remitting multiple sclerosis without impaired cognitive processing speed.
Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
The role of epidemiology in MS research: Past successes, current challenges and future potential.
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
361
362
363
364
365
366
367
368
369
…
next ›
last »